Insiders bought 319K on the open market and sold nothing.
Get an email when CHUC's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Feb 13 | Ryan Stump Chief Operating Officer | Bought | 250,000 | $0.20 | 50K | 0.8% | Form 4 |
| Feb 13 | Henry Sicignano III President | Bought | 250,000 | $0.20 | 50K | 2.6% | Form 4 |
| Feb 13 | Matthew P Montesano Chief Financial Officer | Bought | 100,000 | $0.20 | 20K | 3.7% | Form 4 |
| Feb 13 | Michael D King Director | Bought | 500,000 | $0.20 | 100K | 8.0% | Form 4 |
| Feb 13 | Edward Carmines Director | Bought | 250,000 | $0.20 | 50K | 12% | Form 4 |
| Dec 26, 2025 | Edward Carmines Director | Bought | 100,000 | $0.28 | 28K | 5.2% | Form 4 |
| Dec 17, 2025 | Henry Sicignano III President | Bought | 100,000 | $0.21 | 21K | 1.0% | Form 4 |
| Sep 3, 2025 – Sep 9, 2025 | Edward Carmines Director | Bought 4 parts | 44,723 | $0.29 average | 13K | 2.4% | Form 4 |
- Feb 13Ryan StumpChief Operating Officer · bought 250,000 at $0.2050K0.8% of stake
- Feb 13Henry Sicignano IIIPresident · bought 250,000 at $0.2050K2.6% of stake
- Feb 13Matthew P MontesanoChief Financial Officer · bought 100,000 at $0.2020K3.7% of stake
- Feb 13Michael D KingDirector · bought 500,000 at $0.20100K8.0% of stake
- Feb 13Edward CarminesDirector · bought 250,000 at $0.2050K12% of stake
- Dec 26, 2025Edward CarminesDirector · bought 100,000 at $0.2828K5.2% of stake
- Dec 17, 2025Henry Sicignano IIIPresident · bought 100,000 at $0.2121K1.0% of stake
- Sep 3, 2025 – Sep 9, 2025Edward CarminesDirector · bought 44,723 at avg $0.2913K2.4% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Medicinal Chemicals & Botanical Products · Pick stocks to compare with CHUC
Spot a number that looks wrong? Check it in CHUC's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing CHUC
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.